help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0510
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/8/3330    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mebis, L.
Right arrow Articles by Van den Berghe, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mebis, L.
Right arrow Articles by Van den Berghe, G.
Related Collections
Right arrow Thyroid
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 8 3330-3333
Copyright © 2007 by The Endocrine Society


BRIEF REPORT

The Type II Iodothyronine Deiodinase Is Up-Regulated in Skeletal Muscle during Prolonged Critical Illness

Liese Mebis, Lies Langouche, Theo J. Visser and Greet Van den Berghe

Department of Intensive Care Medicine (L.M., L.L., G.V.d.B.), Katholieke Universiteit Leuven, B-3000 Leuven, Belgium; and Department of Internal Medicine (T.J.V.), Erasmus University Medical Center, 3015 GE Rotterdam, The Netherlands

Address all correspondence and requests for reprints to: Greet Van den Berghe, M.D., Ph.D., Department of Intensive Care Medicine, Catholic University of Leuven, B-3000 Leuven, Belgium. E-mail: greet.vandenberghe{at}med.kuleuven.be.


    Abstract
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
Context: Critical illness is associated with the low T3 syndrome. It remains unclear whether altered type II deiodinase activity (D2) in skeletal muscle contributes to this syndrome.

Objective: Our objective was to study D2 expression and activity in skeletal muscle of acute and prolonged critically ill patients.

Design and Setting: We conducted a clinical observational study in acute and prolonged critical illness with comparison with healthy controls at a university hospital surgical intensive care unit.

Patients: Subjects included 63 prolonged critically ill patients who died in the intensive care unit, 21 acutely ill patients, and 38 controls matched for age, gender, and body mass index.

Results: Elevated expression of the D2 gene and D2 activity in skeletal muscle of prolonged, but not acute, critically ill patients were observed in the face of low circulating thyroid hormone levels.

Conclusions: Reduced D2 activity does not appear to play a role in the pathogenesis of the low T3 syndrome of critical illness.


    Introduction
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
CRITICAL ILLNESS IS associated with a hypercatabolic state and alterations in all hormonal axes. The resulting changes within the hypothalamic-pituitary-thyroid axis, referred to as low T3 syndrome, comprise low circulating T3 levels and elevated rT3 (1, 2). Additionally, the acute phase of critical illness is marked by a transient rise in circulating TSH. When patients enter the chronic phase of illness, also circulating T4 declines, the T3/rT3 ratio further lowers, whereas TSH typically remains within the normal range when measured in a single sample (3). Reduced hypothalamic TRH and GH-secretagogue expression likely plays a role in the neuroendocrine dysfunction of prolonged critical illness (4), because infusion of TRH and GH-releasing peptide 2 has been shown to normalize these changes.

Although the pathogenesis of the low T3 syndrome remains poorly understood, altered peripheral metabolism of thyroid hormones plays a role. The peripheral conversion of thyroid hormones is regulated by three types of iodothyronine deiodinases. Type 1 deiodinase (D1) catalyzes conversion of T4 to T3 and breakdown of rT3, and this enzyme is considered to be the main source of circulating T3. Type 3 deiodinase (D3) inactivates T4 and T3 by conversion to rT3 and 3,3'diiodothyronine (T2), respectively (5). Prolonged critically ill patients have reduced D1 activity and increased D3 activity. This results in a diminished activation and an increased breakdown of thyroid hormone, thereby contributing to the low T3 syndrome (6).

Data on the role of type 2 deiodinase (D2) in the pathogenesis of the low T3 syndrome during critical illness are scarce. D2 converts T4 to T3 and is thus called an activating enzyme. It is expressed in the thyroid, skeletal muscle, pituitary, and brain where it is considered to be important for local thyroid hormone concentrations (7). Recently, it was shown that, in contrast to previous beliefs, D2 expressed in the human muscle may have a significant contribution to circulating T3, particularly in the hypothyroid state (8, 9). We therefore hypothesize that diminished D2 activity during critical illness contributes to the reduced T4 to T3 conversion in the low T3 syndrome.

Measuring D2 activity has been previously attempted in muscle from critically ill patients, but the method lacked sensitivity (6). We studied D2 expression and activity in muscle biopsies from prolonged critically ill patients as compared with acute surgical stressed patients and healthy volunteers.


    Patients and Methods
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
Patients

We studied prolonged critically ill patients who participated in a large randomized controlled study on the effects of intensive insulin treatment in intensive care unit patients (n = 1548), of whom the major clinical outcomes have been published in detail (10). From 63 of the 98 patients who had died in the intensive care unit, good quality RNA from postmortem biopsies was available. Postmortem biopsy samples of skeletal muscle (right musculus rectus abdominis) were taken within minutes after death. Tissue samples were snap-frozen in liquid nitrogen and stored at –80 C until further analysis. Blood samples were stored at –80 C.

For comparison, we studied skeletal muscle (right musculus rectus abdominis) biopsy samples harvested from 22 age-, gender-, and body mass index-matched patients during laparotomy for clinical indications (hemi- or segmentary hepatectomy or restorative rectal resection).

Thirty-eight matched healthy subjects were studied as controls. From 13 of these volunteers, muscle tissue (quadriceps) was sampled under local anesthesia. Because the amount of harvested tissue was limited, six samples were used for RNA isolation and five for activity measurements, and two samples could be used for both measurements.

Characteristics of prolonged ill and acute surgical stressed patients and healthy controls are given in Table 1Go. All protocols were approved by the Institutional Review Board of the Leuven University. Written informed consent was obtained from all healthy volunteers and from the patients or, when the patient was unable to give consent, from the closest family member.


View this table:
[in this window]
[in a new window]

 
TABLE 1. Demographic characteristics of the studied prolonged critically ill patients, patients submitted to acute surgical stress, and healthy volunteers

 
Serum analysis

Commercial RIAs were used to determine total serum T4, T3, TSH (Immunotech, Marseille, France), and rT3 (Biocode Hycel, Liege, Belgium) concentrations. The detection limits were, respectively, 13 nmol/liter, 0.1 nmol/liter, 0.025 mIU/liter, and 0.008 nmol/liter with an intraassay coefficient of variation (CV) of, respectively, 5.1, 3.3, 3.7, and 3%. All samples were assayed in duplicate. A highly specific commercial RIA was used to measure total cortisol (Immunotech) with a sensitivity of 10 nmol/liter and an intraassay CV of 5.8%. All samples were assayed in duplicate. Cortisol-binding globulin (CBG) levels were determined by radial immunodiffusion using an in-house polyclonal antibody raised against purified human CBG as previously described (11), with an interassay CV of 2.1%. Free cortisol was calculated from the total cortisol and CBG levels (12). The validity of applying the formula for critically ill patients was verified previously (13).

D2 activity

Muscle samples were homogenized on ice in 10 vol of PED10 buffer (0.1 M phosphate, 2 mM EDTA, 10 mM dithiothreitol, pH 7.2) using a Polytron (Kinematica AG, Lucerne, Switzerland). Homogenates were cooled on ice and immediately analyzed. Protein concentration was measured with the Bio-Rad protein assay using BSA as the standard following the manufacturer’s instructions. D2 activity was assayed as described previously (9) by duplicate incubation of 500 µg homogenate protein for 240 min at 37 C with 1 nM [3',5'-125I]T4 (100,000 cpm) in a final volume of 0.1 ml PED10 buffer. The incubations were carried out in the absence or presence of 0.5 µM unlabeled T4, which is sufficient to saturate D2. Reactions were stopped by addition of 0.1 ml 100% methanol on ice. After centrifugation, 0.1 ml of the supernatant was added to 0.1 ml 0.02 M ammonium acetate (pH 4.0), and 0.1 ml of the mixture was applied to a 4.6 x 250 mm Symmetry C18 column connected to an Alliance HPLC system (Waters, Etten-Leur, The Netherlands). The column was eluted with a linear gradient of acetonitrile (28–42% in 15 min) in 0.02 M ammonium acetate (pH 4.0) at a flow of 1.2 ml/min. The radioactivity in the eluate was measured online using a Radiomatic A-500 flow scintillation detector (Packard, Meriden, CT). The difference in radioactivity in the T3 peak after incubation without and with excess unlabeled T4 was considered to mirror specific D2 activity.

RNA isolation and real-time PCR

Total RNA was isolated from skeletal muscle tissue using Qiazol lysis reagent (QIAGEN, Venlo, The Netherlands) and subsequently purified using the RNeasy mini RNA isolation kit (QIAGEN). Samples were treated with DNase to remove all contaminating genomic DNA, and 1 µg total RNA was reverse-transcribed using random hexamers.

D2 mRNA levels were quantified in real time with the ABI PRISM 7700 sequence detector (Applied Biosystems, Foster City, CA) which uses TaqMan chemistry for highly accurate quantitation of mRNA levels. We designed primers and probes for D2 (forward, 5'-GCCACATGCCACCTTCTTG-3'; reverse, 5'-GCTGAGCCAAAGTTGACCAC-3'; and probe, 5'-CTTTGCCAGCCCTGAGCGCC-3'). Unknown samples were run in duplicate, and individual samples with a cycle threshold value SD greater than 0.3 were reanalyzed. Data were analyzed using the comparative cycle threshold method. mRNA levels are expressed relative to those of the hypoxanthine guanine phosphoribosyl transferase (HPRT) housekeeping gene (forward, 5'-TGTAGATTTTATCAGACTGAAGAGCTATTGT-3'; reverse, 5'-AAGGAAAGCAAAGTCTGCATTGTT-3'; and probe, 5'-TTTCCAGTTAAAGTTGAGAGATCATCTCCACCAAT-3').

Statistical analysis

Statistical analyses were done using StatView software (SAS Institute Inc., Cary, NC). Data were analyzed using one-way ANOVA tests with a post hoc Fisher’s least significant difference test for multiple comparisons and Mann-Whitney U tests when appropriate. Data are presented as means ± SEM or medians and interquartile ranges when appropriate. Statistical significance was assumed for a two-sided P value < 0.05.


    Results
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
Circulating thyroid hormone and cortisol levels

Circulating total T3 levels were lower in the acute surgical stressed patients as compared with healthy controls, and these levels decreased further in the chronically ill population (Fig. 1Go). Plasma total T4, rT3, and TSH concentrations were comparable in healthy controls and acute surgical stressed patients. In prolonged critical illness, a significant rise in rT3 and a decrease in total T4 and TSH were observed (Fig. 1Go).


Figure 1
View larger version (17K):
[in this window]
[in a new window]

 
FIG. 1. Circulating hormone parameters in healthy volunteers (n = 25) and acute surgical stressed (n = 22) and chronically ill patients (n = 63). Relative D2 mRNA expression levels and D2 activity were measured in human skeletal muscle of healthy volunteers (n = 8 for activity; n = 7 for expression values) and acute surgical stressed (n = 22) and chronically ill patients (n = 32 for activity; n = 63 for expression values). Data are expressed as mean ± SEM. NS, Not significant.

 
Calculated free cortisol levels in prolonged critically ill patients were almost 10-fold higher than in acute surgical stressed patients and healthy controls (Fig. 1Go).

Deiodinase expression and activity in skeletal muscle

Skeletal muscle D2 mRNA levels were similar in acute surgical stressed patients and healthy controls. Prolonged critically ill patients revealed 2-fold higher muscle D2 mRNA levels than healthy controls (Fig. 1Go). Changes in enzyme activity mimicked that of gene expression. D2 activity in skeletal muscle of prolonged critically ill patients was 3-fold higher than in acute surgical stressed patients and healthy controls (Fig. 1Go).

Relationship between D2 expression/activity and levels of thyroid hormones and cortisol during critical illness

Circulating T3 levels showed a weak inverse correlation with skeletal muscle D2 gene expression (r = –0.18; P = 0.09) and activity (r = –0.35; P = 0.009). Circulating T4 levels correlated with D2 activity (r = 0.35; P = 0.01) but not mRNA expression levels.

Free cortisol levels showed a weak but significant correlation with D2 mRNA expression (r = 0.3; P = 0.004) levels but not with D2 activity.


    Discussion
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 
Expression of the D2 gene and D2 activity in skeletal muscle is elevated instead of decreased in prolonged, but not acute, critical illness in the face of low circulating thyroid hormone levels.

The role of D2 in local T3 production has been well accepted, particularly in the brain where it is the only thyroid hormone-activating enzyme (7). Recent data by Maia et al. (8) suggest that expression of D2 in skeletal muscle may significantly contribute to circulating T3, particularly in the hypothyroid state (9). These data generated the hypothesis that a decrease in D2-dependent conversion of T4 into T3 in skeletal muscle could contribute to the low T3 syndrome in critical illness. In contrast to this hypothesis, however, we found increased levels of D2 gene expression and activity in the context of the low T3 syndrome of prolonged but not acute critical illness. The data suggest that at least in the prolonged phase of critical illness, D2 adapts appropriately to the low T3 levels and likely does not contribute to the low T3 syndrome in this condition.

Our observation of increased D2 gene expression and activity in skeletal muscle of chronically ill patients is in contrast to a previous observation. Peeters et al. (6) reported no detectable D2 activity in skeletal muscle of prolonged critically ill patients. The results obtained from the activity measurements in that study may be explained by lack of control samples and suboptimal assay for D2 activity in skeletal muscle based on the release of radioiodide from [3',5'-125I]T4. In our study, we have extended the incubation time and a HPLC system was used for quantitation of [125I]T3 production. In these analyses, the production of [125I]rT3 from [125I]T4 was in good agreement with previous measurements of D3 activity using [125I]T3 as the substrate.

In conclusion, during prolonged but not acute critical illness, D2 gene expression and activity are increased in the face of low circulating thyroid hormone levels. These data indicate that reduced D2 activity does not play a role in the pathogenesis of the low T3 syndrome of prolonged critical illness.


    Acknowledgments
 
We thank P. Wouters, I. Milants, W. Coopmans, and E. Van Herck for their excellent technical assistance. We are grateful to G. Hermans for harvesting muscle biopsies from healthy volunteers. We are indebted to E. Kaptein for the D2 activity measurements.


    Footnotes
 
Disclosure Statement: The authors have nothing to disclose.

First Published Online May 15, 2007

Abbreviations: CBG, Cortisol-binding globulin; CV, coefficient of variation; D1, type 1 deiodinase; D2, type 2 deiodinase; D3, type 3 deiodinase.

Received March 6, 2007.

Accepted May 7, 2007.


    References
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Discussion
 References
 

  1. Docter R, Krenning EP, de Jong M, Hennemann G 1993 The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf) 39:499–518[Medline]
  2. Wartofsky L, Burman KD 1982 Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocr Rev 3:164–217[Medline]
  3. Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V 2001 Dissociation of the early decline in serum T3 concentration and serum IL-6 rise and TNF{alpha} in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab 86:4198–4205[Abstract/Free Full Text]
  4. Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Gouwy S, Stockman W, Weekers F, Schetz M, Lauwers P, Bouillon R, Bowers CY 1997 Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues. Clin Endocrinol (Oxf) 47:599–612[CrossRef][Medline]
  5. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38–89[Abstract/Free Full Text]
  6. Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G 2003 Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88:3202–3211[Abstract/Free Full Text]
  7. Crantz FR, Silva JE, Larsen PR 1982 An analysis of the sources and quantity of 3,5,3'-triiodothyronine specifically bound to nuclear receptors in rat cerebral cortex and cerebellum. Endocrinology 110:367–375[Medline]
  8. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR 2005 Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115:2524–2533[CrossRef][Medline]
  9. Salvatore D, Bartha T, Harney JW, Larsen PR 1996 Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. Endocrinology 137:3308–3315[Abstract]
  10. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359–1367[Abstract/Free Full Text]
  11. Van Baelen H, De Moor P 1974 Immunochemical quantitation of human transcortin. J Clin Endocrinol Metab 39:160–163[Medline]
  12. Coolens JL, Van Baelen H, Heyns W 1987 Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem 26:197–202[Medline]
  13. Vanhorebeek I, Peeters RP, Vander Perre S, Jans I, Wouters PJ, Skogstrand K, Hansen TK, Bouillon R, Van den Berghe G 2006 Cortisol response to critical illness: effect of intensive insulin therapy. J Clin Endocrinol Metab 91:3803–3813[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J EndocrinolHome page
J Kwakkel, O Chassande, H C van Beeren, W M Wiersinga, and A Boelen
Lacking thyroid hormone receptor {beta} gene does not influence alterations in peripheral thyroid hormone metabolism during acute illness
J. Endocrinol., April 1, 2008; 197(1): 151 - 158.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/8/3330    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mebis, L.
Right arrow Articles by Van den Berghe, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mebis, L.
Right arrow Articles by Van den Berghe, G.
Related Collections
Right arrow Thyroid
Right arrow Metabolism


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals